Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6.36M
-
Shares change
-
-313K
-
Total reported value, excl. options
-
$31.4M
-
Value change
-
-$1.43M
-
Number of buys
-
10
-
Number of sells
-
-22
-
Price
-
$4.94
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2014
49 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2014.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.36M shares
of 15M outstanding shares and own 42.48% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (2.61M shares), DIMENSIONAL FUND ADVISORS LP (849K shares), MILLENNIUM MANAGEMENT LLC (575K shares), BlackRock Institutional Trust Company, N.A. (478K shares), NEW YORK STATE COMMON RETIREMENT FUND (298K shares), VANGUARD GROUP INC (272K shares), GW HENSSLER & ASSOCIATES LTD (216K shares), UNITED CAPITAL FINANCIAL ADVISERS, LLC (155K shares), BARD ASSOCIATES INC (89.3K shares), and RENAISSANCE TECHNOLOGIES LLC (84.1K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.